Literature DB >> 28948190

Restoring vision in mice with retinal degeneration using multicharacteristic opsin.

Weldon Wright1, Sivakumar Gajjeraman1, Subrata Batabyal1, Sanjay Pradhan1, Sulagna Bhattacharya1, Vasu Mahapatra1, Ashutosh Tripathy1, Samarendra Mohanty1.   

Abstract

Retinal degenerative diseases, such as retinitis pigmentosa (RP) and dry age-related macular degeneration, have led to loss of vision in millions of individuals. Currently, no surgical or medical treatment is available, although optogenetic therapies are in clinical development. We demonstrate vision restoration using multicharacteristics opsin (MCO1) in animal models with degenerated retina. MCO1 is reliably delivered to specific retinal cells via intravitreal injection of adeno-associated virus (vMCO1), leading to significant improvement in visually guided behavior conducted using a radial arm water maze. The time to reach the platform and the number of error arms decreased significantly after delivery of MCO1. Notably, the improvement in visually guided behavior was observed even at light intensity levels orders of magnitude lower than that required for channelrhodopsin-2 opsin. Viability of vMCO1-treated retina is not compromised by chronic light exposure. Safe virus-mediated MCO1 delivery has potential for effective gene therapy of diverse retinal degenerations in patients.

Entities:  

Keywords:  dry age-related macular degeneration; optogenetics; retinitis pigmentosa; vision restoration

Year:  2017        PMID: 28948190      PMCID: PMC5603575          DOI: 10.1117/1.NPh.4.4.041505

Source DB:  PubMed          Journal:  Neurophotonics        ISSN: 2329-423X            Impact factor:   4.212


  24 in total

1.  Millisecond-timescale, genetically targeted optical control of neural activity.

Authors:  Edward S Boyden; Feng Zhang; Ernst Bamberg; Georg Nagel; Karl Deisseroth
Journal:  Nat Neurosci       Date:  2005-08-14       Impact factor: 24.884

2.  Optobionic vision--a new genetically enhanced light on retinal prosthesis.

Authors:  Patrick Degenaar; Nir Grossman; Muhammad Ali Memon; Juan Burrone; Martin Dawson; Emmanuel Drakakis; Mark Neil; Konstantin Nikolic
Journal:  J Neural Eng       Date:  2009-05-20       Impact factor: 5.379

3.  In-depth activation of channelrhodopsin 2-sensitized excitable cells with high spatial resolution using two-photon excitation with a near-infrared laser microbeam.

Authors:  Samarendra K Mohanty; Rainer K Reinscheid; Xiaobin Liu; Naoe Okamura; Tatiana B Krasieva; Michael W Berns
Journal:  Biophys J       Date:  2008-07-11       Impact factor: 4.033

Review 4.  Maze procedures: the radial-arm and water maze compared.

Authors:  H Hodges
Journal:  Brain Res Cogn Brain Res       Date:  1996-06

5.  Predicting visual sensitivity in retinal prosthesis patients.

Authors:  Alan Horsager; Scott H Greenwald; James D Weiland; Mark S Humayun; Robert J Greenberg; Matthew J McMahon; Geoffrey M Boynton; Ione Fine
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-20       Impact factor: 4.799

6.  Optical interrogation of neural circuits in Caenorhabditis elegans.

Authors:  Zengcai V Guo; Anne C Hart; Sharad Ramanathan
Journal:  Nat Methods       Date:  2009-11-08       Impact factor: 28.547

7.  Channelrhodopsin-2, a directly light-gated cation-selective membrane channel.

Authors:  Georg Nagel; Tanjef Szellas; Wolfram Huhn; Suneel Kateriya; Nona Adeishvili; Peter Berthold; Doris Ollig; Peter Hegemann; Ernst Bamberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-13       Impact factor: 11.205

8.  Subretinal electronic chips allow blind patients to read letters and combine them to words.

Authors:  Eberhart Zrenner; Karl Ulrich Bartz-Schmidt; Heval Benav; Dorothea Besch; Anna Bruckmann; Veit-Peter Gabel; Florian Gekeler; Udo Greppmaier; Alex Harscher; Steffen Kibbel; Johannes Koch; Akos Kusnyerik; Tobias Peters; Katarina Stingl; Helmut Sachs; Alfred Stett; Peter Szurman; Barbara Wilhelm; Robert Wilke
Journal:  Proc Biol Sci       Date:  2010-11-03       Impact factor: 5.349

9.  ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation.

Authors:  John Y Lin; Per Magne Knutsen; Arnaud Muller; David Kleinfeld; Roger Y Tsien
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884

10.  Broad-Band Activatable White-Opsin.

Authors:  Subrata Batabyal; Gregory Cervenka; Ji Hee Ha; Young-Tae Kim; Samarendra Mohanty
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

View more
  6 in total

Review 1.  Rhodopsins: An Excitingly Versatile Protein Species for Research, Development and Creative Engineering.

Authors:  Willem J de Grip; Srividya Ganapathy
Journal:  Front Chem       Date:  2022-06-22       Impact factor: 5.545

2.  Nano-enhanced Optical Gene Delivery to Retinal Degenerated Mice.

Authors:  Subrata Batabyal; Sivakumar Gajjeraman; Sulagna Bhattacharya; Weldon Wright; Samarendra Mohanty
Journal:  Curr Gene Ther       Date:  2019       Impact factor: 4.391

3.  Vision Restoration by Optogenetic Therapy and Developments Toward Sonogenetic Therapy.

Authors:  Matthieu Provansal; Katia Marazova; José Alain Sahel; Serge Picaud
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

4.  Monitoring Visual Cortical Activities During Progressive Retinal Degeneration Using Functional Bioluminescence Imaging.

Authors:  Darryl Narcisse; Sourajit M Mustafi; Michael Carlson; Sanghoon Kim; Subrata Batabyal; Weldon Wright; Samarendra K Mohanty
Journal:  Front Neurosci       Date:  2021-10-04       Impact factor: 5.152

Review 5.  Advances in Ophthalmic Optogenetics: Approaches and Applications.

Authors:  Philipp P Prosseda; Matthew Tran; Tia Kowal; Biao Wang; Yang Sun
Journal:  Biomolecules       Date:  2022-02-08

6.  Sensitization of ON-bipolar cells with ambient light activatable multi-characteristic opsin rescues vision in mice.

Authors:  Subrata Batabyal; Sivakumar Gajjeraman; Sanjay Pradhan; Sulagna Bhattacharya; Weldon Wright; Samarendra Mohanty
Journal:  Gene Ther       Date:  2020-10-22       Impact factor: 4.184

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.